GlassScriptPhysician profile
James N Wheeler
NPI 1033304928
$3,864.58
in general payments reported to CMS, 2019-2025
20 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $564 · 2023: $891 · 2024: $927 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,905.59 |
| Education | $177.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,485.15 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $650.69 | 2022-2025 | Ilumya, Winlevi, Absorica Ld |
| Incyte Corporation | $360.47 | 2022-2025 | Opzelura |
| Pfizer INC. | $188.96 | 2021-2025 | |
| Leo Pharma INC. | $188.50 | 2022-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $172.02 | 2021-2025 | |
| Organon LLC | $148.45 | 2023-2025 | Hadlima, Nexplanon, Vtama |
| Amgen INC. | $145.29 | 2024-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $109.50 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $108.58 | 2022-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $75.61 | 2023 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $60.54 | 2021-2025 | |
| Lilly USA, LLC | $32.32 | 2023-2025 | Olumiant, Taltz, Ebglyss |
| Surgenex LLC | $31.96 | 2025 | Surgraft, Renograft, Pellograft |
| Elite Orthopedics, LLC | $25.99 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $24.38 | 2021 | |
| Botanix Sb INC | $18.90 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $17.03 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $14.34 | 2025 | Aklief |
| Biofrontera INC. | $5.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.